Researchers from the Massachusetts Institute of Technology in the United States have harnessed cutting-edge optogenetics technology to uncover three novel compounds—IBX-200, IBX-202, and IBX-204—that activate the cell's intrinsic defense mechanisms. Experimental evidence demonstrates these compounds' efficacy in warding off various viral attacks, potentially paving the way for the creation of broad-spectrum antiviral medications.